EU AstraZeneca Ruling Raises Bar For IP Monopoly Abuse
The European Union's highest court refused Thursday to overturn a €52.5 million ($68 million) abuse of dominance fine against AstraZeneca PLC, but it did raise the bar for the kinds of...To view the full article, register now.
Already a subscriber? Click here to view full article